DK101888D0 - Immunmodulerende midler og anvendelse af disse - Google Patents

Immunmodulerende midler og anvendelse af disse

Info

Publication number
DK101888D0
DK101888D0 DK101888A DK101888A DK101888D0 DK 101888 D0 DK101888 D0 DK 101888D0 DK 101888 A DK101888 A DK 101888A DK 101888 A DK101888 A DK 101888A DK 101888 D0 DK101888 D0 DK 101888D0
Authority
DK
Denmark
Prior art keywords
region
compositions
cells
relation
application
Prior art date
Application number
DK101888A
Other languages
English (en)
Other versions
DK101888A (da
Inventor
Malcolm L Gefter
Jean-Gerard Guillet
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27360777&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK101888(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of DK101888D0 publication Critical patent/DK101888D0/da
Publication of DK101888A publication Critical patent/DK101888A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK101888A 1986-06-30 1988-02-26 Immunmodulerende midler og anvendelse af disse DK101888A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88013486A 1986-06-30 1986-06-30
US92428686A 1986-10-29 1986-10-29
US1734387A 1987-02-20 1987-02-20
PCT/US1987/001532 WO1988000057A1 (en) 1986-06-30 1987-06-26 Immunomodulating compositions and their use

Publications (2)

Publication Number Publication Date
DK101888D0 true DK101888D0 (da) 1988-02-26
DK101888A DK101888A (da) 1988-04-26

Family

ID=27360777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK101888A DK101888A (da) 1986-06-30 1988-02-26 Immunmodulerende midler og anvendelse af disse

Country Status (8)

Country Link
EP (1) EP0271577B1 (da)
JP (2) JP2633881B2 (da)
KR (1) KR880701108A (da)
AT (1) ATE128627T1 (da)
AU (1) AU603131B2 (da)
DE (1) DE3751553T2 (da)
DK (1) DK101888A (da)
WO (1) WO1988000057A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039947A (en) * 1987-06-24 2000-03-21 Autoimmune, Inc. Peptides derived from immunodominant epitopes of myelin basic protein
US5849298A (en) * 1987-06-24 1998-12-15 Autoimmune Inc. Treatment of multiple sclerosis by oral administration of bovine myelin
US6645504B1 (en) 1987-06-24 2003-11-11 Autoimmune Inc. Bystander suppression of type I diabetes by oral administration of glucagon
US5843445A (en) * 1987-06-24 1998-12-01 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5641474A (en) * 1987-06-24 1997-06-24 Autoimmune, Inc. Prevention of autoimmune diseases by aerosol administration of autoantigens
US5869054A (en) * 1987-06-24 1999-02-09 Autoimmune Inc. Treatment of multiple sclerosis by oral administration of autoantigens
US5645820A (en) * 1987-06-24 1997-07-08 Autoimmune, Inc. Treatment of autoimmune diseases by aerosol administration of autoantigens
EP0666080B1 (en) † 1987-06-24 2004-01-21 Brigham & Women's Hospital Treatment of autoimmune diseases by oral administration of autoantigens
CA1335792C (en) * 1987-08-18 1995-06-06 Chaim O. Jacob Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
EP0400077A4 (en) * 1988-02-12 1990-12-27 The Regents Of The University Of California Use of synthetic peptides to generate and manipulate cellular immunity
DE68924850T2 (de) * 1988-06-14 1996-10-10 Cell Med Inc Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
US6106840A (en) * 1988-06-23 2000-08-22 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
US5260422A (en) * 1988-06-23 1993-11-09 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
US5468481A (en) * 1988-06-23 1995-11-21 Amergen, Inc. MHC class II-peptide conjugates useful in ameliorating autoimmunity
US5858980A (en) * 1990-03-30 1999-01-12 Autoimmune, Inc. Peptide fragments of myelin basic protein
IL99754A (en) * 1990-10-15 1996-08-04 Autoimmune Inc Pharmaceutical preparation containing autoantib or particle or analogue for the treatment of autoimmune arthritis and multiple sclerosis
US7090982B2 (en) 1991-10-22 2006-08-15 The Governors Of The University Of Alberta Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient
US6252040B1 (en) 1991-10-22 2001-06-26 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
US6251396B1 (en) 1994-11-18 2001-06-26 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
US6379670B1 (en) 1994-11-18 2002-04-30 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
WO1997035193A1 (en) 1996-03-21 1997-09-25 Imperial College Of Science, Technology And Medicine Cryptic peptides and method for their identification
DE102011004335A1 (de) 2011-02-17 2012-08-23 Thomas Grammel Verfahren zur Herstellung eines Vakzins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1979000160A1 (en) 1977-09-28 1979-04-05 Nat Res Dev Improvements in or relating to immunological preparations
US4469677A (en) 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
US4565696A (en) 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US4473555A (en) 1983-10-17 1984-09-25 Syntex (U.S.A.) Inc. Nona- and dodecapeptides for augmenting natural killer cell activity
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants

Also Published As

Publication number Publication date
JP2633881B2 (ja) 1997-07-23
JPH09176042A (ja) 1997-07-08
EP0271577A4 (en) 1990-01-08
ATE128627T1 (de) 1995-10-15
DE3751553T2 (de) 1996-04-25
DK101888A (da) 1988-04-26
AU7752487A (en) 1988-01-29
DE3751553D1 (de) 1995-11-09
JPH01500595A (ja) 1989-03-01
KR880701108A (ko) 1988-07-25
AU603131B2 (en) 1990-11-08
JP2828960B2 (ja) 1998-11-25
EP0271577B1 (en) 1995-10-04
WO1988000057A1 (en) 1988-01-14
EP0271577A1 (en) 1988-06-22

Similar Documents

Publication Publication Date Title
DK101888A (da) Immunmodulerende midler og anvendelse af disse
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
DE68925226D1 (de) Monoklonale Antikörper
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
DK0584715T3 (da) Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
PT100978A (pt) Peptidos recombitopos, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem e seu uso
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DK0474691T3 (da) Monoklonale antistoffer til induktion af tolerance
DE69738965D1 (de) Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente
Low et al. Thymosin and other thymic hormones and their synthetic analogues
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
FI950248A0 (fi) Rokotteita monisoluisia loisia vastaan
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
FI854839L (fi) Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid.
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
DE69322960D1 (de) Empfängnisverhütender impfstoff
PT85248A (fr) Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants
NO952506L (no) Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment